The Role of a Pathological Interaction between β-amyloid and Mitochondria in the Occurrence and Development of Alzheimer’s Disease
Open Access
- 29 October 2022
- journal article
- review article
- Published by Acta Naturae Ltd in Acta Naturae
- Vol. 14 (3) , 19-34
Abstract
Alzheimers disease (AD) is one of the most common neurodegenerative diseases in existence. It is characterized by an impaired cognitive function that is due to a progressive loss of neurons in the brain. Extracellular -amyloid (A) plaques are the main pathological features of the disease. In addition to abnormal protein aggregation, increased mitochondrial fragmentation, altered expression of the genes involved in mitochondrial biogenesis, disruptions in the ERmitochondria interaction, and mitophagy are observed. Reactive oxygen species are known to affect A expression and aggregation. In turn, oligomeric and aggregated A cause mitochondrial disorders. In this review, we summarize available knowledge about the pathological effects of A on mitochondria and the potential molecular targets associated with proteinopathy and mitochondrial dysfunction for the pharmacological treatment of Alzheimers disease.Keywords
This publication has 229 references indexed in Scilit:
- Modulation of the endoplasmic reticulum–mitochondria interface in Alzheimer’s disease and related modelsProceedings of the National Academy of Sciences, 2013
- Cyclophilin D Deficiency Rescues Axonal Mitochondrial Transport in Alzheimer’s NeuronsPLOS ONE, 2013
- Upregulated function of mitochondria‐associated ER membranes in Alzheimer diseaseThe EMBO Journal, 2012
- Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damageHuman Molecular Genetics, 2012
- Inhibition of Amyloid-β (Aβ) Peptide-Binding Alcohol Dehydrogenase-Aβ Interaction Reduces Aβ Accumulation and Improves Mitochondrial Function in a Mouse Model of Alzheimer's DiseaseJournal of Neuroscience, 2011
- RAGE-mediated signaling contributes to intraneuronal transport of amyloid-β and neuronal dysfunctionProceedings of the National Academy of Sciences, 2009
- Amyloid-β and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease miceProceedings of the National Academy of Sciences, 2009
- PGC-1α Expression Decreases in the Alzheimer Disease Brain as a Function of DementiaArchives of Neurology, 2009
- Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteinsProceedings of the National Academy of Sciences, 2008
- The amyloid β-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristaeProceedings of the National Academy of Sciences, 2008